TNXP Tonix Pharmaceuticals Holding Corp.

8-K Current Report

Filed: March 13, 2026

Health Care

Pharmaceutical Preparations

Tonix Pharmaceuticals Holding Corp. Overview

Tonix Pharmaceuticals Holding Corp. (TNXP) 8-K current report filed with SEC EDGAR on March 13, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q1 2025 earnings press release filed under Item 2.02 — actual financial figures contained in referenced exhibit, not in filing body
• Exhibit disclosure structured to avoid Section 18 Exchange Act liability — standard "furnished not filed" treatment

+1 more insights

Other Tonix Pharmaceuticals Holding Corp. 8-K Filings

8-K Mar 18, 2026

8-K Mar 10, 2026

8-K Mar 3, 2026

Get deeper insights on Tonix Pharmaceuticals Holding Corp.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.